Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study

Early tumor shrinkage (ETS) and depth of response (DoR) predict favorable outcomes in metastatic colorectal cancer. We aim to evaluate their prognostic role in metastatic pancreatic cancer (PC) patients treated with first-line modified-FOLFIRINOX (FOLFOXIRI) or Gemcitabine + Nab-paclitaxel (GemNab)....

Descripción completa

Detalles Bibliográficos
Autores principales: Vivaldi, Caterina, Fornaro, Lorenzo, Cappelli, Carla, Pecora, Irene, Catanese, Silvia, Salani, Francesca, Cacciato Insilla, Andrea, Kauffmann, Emanuele, Donati, Francescamaria, Pasquini, Giulia, Massa, Valentina, Napoli, Niccolò, Lencioni, Monica, Boraschi, Piero, Campani, Daniela, Boggi, Ugo, Caramella, Davide, Falcone, Alfredo, Vasile, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678367/
https://www.ncbi.nlm.nih.gov/pubmed/31277449
http://dx.doi.org/10.3390/cancers11070939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678367/
https://www.ncbi.nlm.nih.gov/pubmed/31277449
http://dx.doi.org/10.3390/cancers11070939

Ejemplares similares